Medspera Pharmaceuticals Private Limited

Jardiance (empagliflozin) is a medication used to improve glycemic control in adults with type 2 diabetes, reduce cardiovascular death risk in heart failure patients, and slow the progression of chronic kidney disease (CKD). It acts as an SGLT2 inhibitor, causing kidneys to remove excess glucose, salt, and water through urine. 

Jardiance (empagliflozin) is used to improve glycemic control in adults with type 2 diabetes, often in conjunction with diet and exercise. It is also indicated for reducing the risk of cardiovascular death in adults with type 2 diabetes and cardiovascular disease, and for reducing the risk of hospitalization in patients with heart failure or chronic kidney disease. 

Forxiga (dapagliflozin) is a medication used to manage Type 2 diabetes by increasing urinary glucose excretion. It is also prescribed to reduce the risk of hospitalization for heart failure and to manage chronic kidney disease in adults. 

Forxiga (dapagliflozin) is a medication used to improve glycemic control in adults with type 2 diabetes, typically alongside diet and exercise. As an SGLT2 inhibitor, it helps the kidneys remove excess sugar from the body through urine. It is also used to manage heart failure and chronic kidney disease. 

Trajenta 5mg tablet (linagliptin) is a prescription oral medication used to improve blood sugar control in adults with type 2 diabetes, typically alongside diet and exercise. As a DPP-4 inhibitor, it increases hormones that stimulate insulin production and lower glucagon, which helps regulate glucose levels.